Sinofn Health
Sinofn Health
In an era where consumers demand transparency and efficacy, the nutraceutical landscape has shifted from generic formulation to science-driven customization. SINOFN stands at the forefront of this evolution, bridging the gap between clinical research and commercial product development.
International brands are moving away from simple private label providers toward comprehensive ODM partners. Today's procurement demands focus on traceability, bio-availability, and clean-label certifications. Whether it is sourcing high-purity NMN or developing complex FSMP (Foods for Special Medical Purposes), brands require a supplier that operates as an extension of their R&D team.
The convergence of biotechnology and food science is the "Information Gain" that modern brands leverage to win. SINOFN utilizes its backing from the Chinese Academy of Sciences to deliver not just products, but intellectual property and formulation strategies. By optimizing ingredient delivery systems—such as our proprietary peptide and encapsulated formulations—we ensure higher absorption rates and improved stability in shelf-life testing.
Founded in 2012 by Mrs. GuoHong Liu, SINOFN was built on a foundation of clinical empathy and scientific rigor. Having witnessed the struggles of those with metabolic disorders, the company pivoted toward high-standard medical nutrition. Today, this mission underpins our commercial ODM capabilities.
Our Tianjin R&D center, powered by collaboration with top-tier universities, is led by an international team including Dr. Zhang Ying (CAS Postdoc) and Hans van Dijk (Netherlands). This combination of Eastern raw-material access and Western formulation engineering allows SINOFN to maintain a technical advantage in the competitive supplement market.
Future-proofing your supply chain requires a proactive approach to regulatory standards. SINOFN doesn't just meet requirements; we anticipate market changes.
A: Yes. We offer pilot-scale production lines designed specifically to validate formulations before committing to full-scale manufacturing, mitigating market risk.
A: It provides us with direct access to advanced biochemical research, allowing for superior ingredient stabilization and the development of unique, patentable formulations.
A: Absolutely. Our facilities are audited to meet international standards including ISO and BRCGS, ensuring that our products meet the regulatory quality expectations of EU, US, and Asian markets.
